Drug Development


alopeciac-july24.jpg Studies on reversing the signs of aging like wrinkles and hair loss are of considerable interest to researchers and public at large. But what if these telltale signs of aging can be reversed?

BillGates-CuringAlzheimers-111317.jpg Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.

Bristol-Myers Squibb Co. (BMY) announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel or dasatinib tablets to include the treatment of children with Philadelphia chromosome-positive or Ph+ chronic myeloid leukemia or CML in chronic phase or CP. The approval for...

FDA-Approved-Oct-110717.jpg Yet another month has gone by, and it's time again to take a look-back at the new drugs that successfully crossed the therapeutics finish line. At the time of writing, 37 novel drugs were approved by the FDA for this year. This compares favorably with 22 novel drugs that were approved for the whole of 2016. Click here for the list of new drugs approved in October.

Alexion Pharmaceuticals Inc. (ALXN) said that the U.S. Food and Drug Administration has approved Soliris or eculizumab as a treatment for adult patients with generalized myasthenia gravis or gMG who are anti-acetylcholine receptor or AchR antibody-positive. In the Phase 3 REGAIN study and its ongoing...

Follow RTT